Literature DB >> 4556640

Depression of growth in hyperactive children on stimulant drugs.

D Safer, R Allen, E Barr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4556640     DOI: 10.1056/NEJM197208032870503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

Review 1.  Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.

Authors:  Timothy E Wilens; Thomas J Spencer
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

Review 2.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

3.  Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.

Authors:  Laurence L Greenhill; James M Swanson; Lily Hechtman; James Waxmonsky; L Eugene Arnold; Brooke S G Molina; Stephen P Hinshaw; Peter S Jensen; Howard B Abikoff; Timothy Wigal; Annamarie Stehli; Andrea Howard; Michael Hermanussen; Tomasz Hanć
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-15       Impact factor: 8.829

4.  Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Authors:  Kathryn E Gill; Peter J Pierre; James Daunais; Allyson J Bennett; Susan Martelle; H Donald Gage; James M Swanson; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

Review 5.  Growth on stimulant medication; clarifying the confusion: a review.

Authors:  A Poulton
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

Review 6.  Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

Authors:  Lily Hechtman; Brian Greenfield
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.

Authors:  Panayotis K Thanos; Lisa S Robison; Jessica Steier; Yu Fen Hwang; Thomas Cooper; James M Swanson; David E Komatsu; Michael Hadjiargyrou; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2015-01-29       Impact factor: 3.533

8.  Effect of long-term treatment of hyperactive children with methylphenidate.

Authors:  G Weiss; E Kruger; U Danielson; M Elman
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

Review 9.  The hyperkinetic child: some misleading assumptions.

Authors:  P S Stephenson
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

10.  Disruptive behavior: a dietary approach.

Authors:  D O'Banion; B Armstrong; R A Cummings; J Stange
Journal:  J Autism Child Schizophr       Date:  1978-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.